BNET Industries

Quest Diagnostics Inc.

(DGX) is in the Health Care Industry

Market Cap:$11.3B
Last Fiscal Year Sales:$6.7B
  • Public
  • US
Dow Jones Description

We are the nations leading provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health. We offer patients and physicians the broadest access to diagnostic laboratory services through our nationwide network of laboratories and our own patient service centers. We provide interpretive consultation through the largest medical and scientific staff in the industry, with approximately 900 M.D.s and Ph.D.s around the country. We are the leading provider of esoteric testing, including gene-based testing, the leading provider of anatomic pathology services, including dermatopathology, and the leading provider of testing for drugs of abuse. We are also a leading provider of testing for clinical trials and risk assessment services for the life insurance industry. We empower healthcare organizations and clinicians with state-of-the-art information technology solutions that can improve patient care and medical practice. During 2006, we generated net revenues of $6.3 billion and processed approximately 151 million requisitions for testing. Each requisition form accompanies a patient specimen, indicating the tests to be performed and the party to be billed for the tests. Our customers include patients, physicians, hospitals, employers, governmental institutions and other commercial clinical laboratories. ...

Number of Employees 42,800
Contact Information

1290 Wall St W

Lyndhurst, New Jersey 07071

questdiagnostic...

1 201 393 5000

NAICS Code Medical Laboratories: 621511

Recent Events

  • Quest Diagnostics Declares Quarterly Cash Dividend

    12/14/09 - Stock Split / Dividend - View Story

  • Quest Diagnostics To Offer $750 Million Of Senior Notes; Begins Cash Tender Offer For Outstanding...

    11/12/09 - Licensing / Contract - View Story

  • BRIEF-Moody's rates Quest Diagnostics new senior notes Baa3

    11/12/09 - Bond / Stock Rating - View Story

  • LabCorp 3Q Profit Rises 17% Amid Cost Controls

    10/22/09 - Financial Announcement - View Story

  • Lazard Capital Initiates Coverage on Quest Diagnostics DGX with a Hold

    10/16/09 - Bond / Stock Rating - View Story

  • Post a Comment

    10/21/09 - Financial Announcement - View Story

  • Whistleblower Law Firm Phillips & Cohen Selected for 2009 'Hot List' of Plaintiffs' Law Firms

    10/05/09 - Legal Settlement - View Story

  • Sector Snap: Quest and LabCorp downgraded

    9/16/09 - Bond / Stock Rating - View Story

  • Credit Suisse Downgrades Quest Diagnostics DGX To Neutral

    9/16/09 - Bond / Stock Rating - View Story

News & Analysis

healthcare and quest diagnostics inc. - All News and Analysis

advertisement
     DGX $61.44 +1.01 (1.67% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 1,446,580
Shares Outstanding 184.90M
Market Cap 11.4B
Year High 61.61
Year Low 42.36
Earnings Per Share 3.78
P/E Ratio 16.25
Dividend 0.40
Yield 0.65
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Presented by American Express